SWITCH BIOTECH Release: First Clinical Results In The Treatment Of Psoriasis
10/19/2005 5:10:46 PM
SWITCH Biotech, a biotechnology company that is specialized in the treatment of skin diseases, announced first breakthroughs in the clinical development of its innovative medicaments for the treatment of psoriasis. The first clinical trial of the active compound SWT01.100 provided valuable data that support the innovative principle of function.
comments powered by